roseoflavin has been researched along with ribocil in 1 studies
| Studies (roseoflavin) | Trials (roseoflavin) | Recent Studies (post-2010) (roseoflavin) | Studies (ribocil) | Trials (ribocil) | Recent Studies (post-2010) (ribocil) |
|---|---|---|---|---|---|
| 48 | 0 | 29 | 5 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, CM; Flattery, A; Galgoci, AM; Gill, C; Howe, JA; Mack, M; Malinverni, JC; Mann, PA; Mayhood, T; McCurry, MD; Murgolo, N; Roemer, T; Sher, X; Villafania, A; Wang, H; Xiao, L | 1 |
1 other study(ies) available for roseoflavin and ribocil
| Article | Year |
|---|---|
Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Escherichia coli; Flavin Mononucleotide; Homeostasis; Methicillin-Resistant Staphylococcus aureus; Mice; Models, Molecular; Molecular Targeted Therapy; Protein Conformation; Pyrimidines; Riboflavin; Riboswitch; Staphylococcus aureus | 2017 |